News

• Over-the-counter alpha-blocker for BPH
• Published on Apr 29, 2010

The alpha-blocker tamsulosin is now available from pharmacies without prescription for the symptomatic treatment of benign prostatic hypertrophy (BPH) in men aged 45–75.  

• Fesoterodine tops tolterodine
• Published on Apr 29, 2010

Fesoterodine (Toviaz) is superior to tolterodine (Detrusitol ER) in reducing urge episodes and increasing bladder capacity in people with overactive bladder, according to data announced by manufacturer Pfizer at the 25th European Association of Urology Annual Congress in Barcelona.  

• Promise in castration-resistant prostate cancer
• Published on Apr 29, 2010

A new androgen blocker has shown promising efficacy in a Phase 1–2 trial in men with progressive, metastatic, castration-resistant prostate cancer (Lancet 2010;375:1437–46).

• Men with prostate cancer need more support
• Published on Apr 29, 2010

Men need more help to cope with the emotional impact of a diagnosis of prostate cancer, a survey has shown.        

• Broad protection from quadrivalent HPV vaccine
• Published on Feb 23, 2010

Merck’s human papillomavirus (HPV) vaccine Gardasil protects women not only against HPV 6/11/16/18 but also reduces the risk of other cervical lesions and genital warts (J Nat Cancer Inst 2010; published online 5 February; doi: 10.1093/jnci/djp534).